Gritstone bio Inc to Discuss the Results from First Cohort of CORAL-BOOST Study- Conference Call Transcript
Greetings. Welcome to Gritstone bio's conference call. (Operator Instructions) Please note that today's conference is being recorded. At this time, I'll now turn the conference over to Andrew Allen, Co-Founder, President and CEO. Mr. Allen, you may now begin.
Thank you. Well, good morning, everybody. It's a great pleasure to be with you this morning and to present the first data off of our self-amplifying mRNA platform in infectious disease. We'll be taking about 30 minutes to go through the data presentation, and then we'll be opening up for another 30 minutes or so of Q&A.
We'll be making some forward-looking statements today, and the agenda is shown on the slide that's on your screen now. I'll do a brief overview of Gritstone bio, and then I will be handing over to my colleague, Dr. Karin Jooss, who is our Executive Vice President and Head of R&D; and Karin will walk you through the specific data from the first cohort of healthy volunteers who are over the age
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |